ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Sacharin Issue Splits Scientists; ACS Proposes Delaney Changes

April 15, 1977

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

CCOPs, Research Base Awards Are Listed

November 19, 1993

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014